Ustekinumab as Induction and Maintenance Therapy in Patients With IBD and Type 2 Autoimmune Pancreatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Crohn's & Colitis
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ustekinumab as induction and maintenance therapy in patients with inflammatory bowel disease and type II autoimmune pancreatitis: report of two cases
J Crohns Colitis 2023 Apr 22;[EPub Ahead of Print], G Lauri, F D'Amico, M Allocca, D Palumbo, E Della-Torre, F De Cobelli, C Doglioni, PG Arcidiacono, G Capurso, S DaneseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.